000			02142nam a22003375i 4500
001			318241
003			MX-SnUAN
005			20160429161120.0
007			cr nn 008mamaa
008			160111s2015 gw | s |||| 0|eng d
020			_a9783319115146 _9978-3-319-11514-6
035			_avtls000418850
039		9	_y201601110907 _zstaff
050		4	_aRM1-950
245	1	0	_aDrug treatment of sleep disorders / _cedited by Antonio Guglietta.
264		1	_aCham : _bSpringer International Publishing : _bSpringer, _c2015.
300			_aviii, 297 páginas : _b23 ilustraciones, 14 ilustraciones en color.
336			_atexto _btxt _2rdacontent
337			_acomputadora _bc _2rdamedia
338			_arecurso en línea _bcr _2rdacarrier
347			_aarchivo de texto _bPDF _2rda
490	0		_aMilestones in Drug Therapy, _x2296-6056
500			_aSpringer eBooks
505	0		_aAn overview of sleep physiology and sleep regulation -- Neuronal networks regulating sleep and arousal: effect of drugs -- Classification of sleep disorders -- Development of new therapeutical agents for treatment of insomnia and other sleep disorders -- Low dose doxepin for insomnia -- Lorediplon: a new GABAa modulator drug for treatment of insomnia -- Zolpidem sublingual formulations -- Eszopiclone: review and clinical applications in chronic and co-morbid insomnia -- Orexin/hypocretin antagonists in insomnia: from bench to clinic -- Modafinil and armodafinil -- Sodium oxybate (Xyrem®): a new and effective treatment for narcolepsy with cataplexy -- Cell therapy to treat narcolepsy -- Tasimelteon -- The past, present and future of drug development and treatment in sleep disorders.
590			_aPara consulta fuera de la UANL se requiere clave de acceso remoto.
700	1		_aGuglietta, Antonio, _eeditor. _9362083
710	2		_aSpringerLink (Servicio en línea) _9299170
776	0	8	_iEdición impresa: _z9783319115139
856	4	0	_uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-3-319-11514-6 _zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL)
942			_c14
999			_c318241 _d318241